The Food and Drugs Administration (FDA) asked patients who underwent stem cell treatment and suffered adverse reactions to submit a report online.
Those who have availed such products or therapies and have experienced any untoward event or side effect or treatment failures as well as those currently availing such are highly encouraged to submit reports through the FDA website at http://www.fda.gov.ph under eReport and ADR (Adverse Drug Reaction) Report Section, FDA Advisory no. 2013-023 said. The government agency assured all reports will be treated with confidentiality.
This advisory is being issued as part of FDAs initiative to empower consumers in the surveillance and monitoring of drug safety, the advisory added.
Early this week, the Department of Health (DoH) announced the deadline for the application for accreditation of hospitals and health facilities offering stem cell-based treatments in the Philippines.
The Bureau of Health Facilities (BHFS) will lead the assessment of the health facilities.
Applications will be reviewed jointly by a bio-ethics committee and a hospital-based review board.
Some five big hospitals in Metro Manila have already submitted their application for accreditation. (Jenny F. Manongdo)
Previous
Next
Follow this link:
Stem cell clients urged to report side effects